Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06889584 · ClinicalTrials.gov registry record · NA

Supplement Combination on Stress and Sleep

A NA study, sponsored by University of South Carolina.

Completed
Registry status
NA
Development phase
115
Enrollment target

NCT06889584 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 115 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06889584, a NA study, has completed, sponsored by University of South Carolina.

COMPLETED
Registry status
NA
Development phase
115 participants
Enrollment target

Study Summary

The purpose of this clinical trial is to assess the effects of a supplement combination on measures of sleep quality and stress in healthy adults.

Interventions

  • COMBINATION_PRODUCT All Active Supplement Combinations (Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin))
  • COMBINATION_PRODUCT AM Active Supplement Combination (Ashwagandha and Rhodiola rosea)
  • COMBINATION_PRODUCT PM Active Supplement Combination (Magnesium threonate, L-theanine, and apigenin)
  • OTHER AM and PM Placebo

Trial Details

FieldValue
Enrollment Target 115 participants
Start Date 2025-02-15
Est. Completion 2026-02-01
Phase NA

Sponsor

University of South Carolina

157 total trials

What the Registry Record Tells You About NCT06889584

The ClinicalTrials.gov registry entry for NCT06889584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of South Carolina, which has 157 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which All Active Supplement Combinations (Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin)) is the first listed.

NCT06889584 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06889584 about?

NCT06889584 is a clinical study titled "Supplement Combination on Stress and Sleep". The purpose of this clinical trial is to assess the effects of a supplement combination on measures of sleep quality and stress in healthy adults.

What is the current status of trial NCT06889584?

This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2025-02-15. Estimated completion is 2026-02-01.

What interventions are being tested in trial NCT06889584?

The interventions under investigation include: All Active Supplement Combinations (Ashwagandha, Rhodiola rosea, magnesium threonate, L-theanine, and apigenin)) (COMBINATION_PRODUCT), AM Active Supplement Combination (Ashwagandha and Rhodiola rosea) (COMBINATION_PRODUCT), PM Active Supplement Combination (Magnesium threonate, L-theanine, and apigenin) (COMBINATION_PRODUCT), AM and PM Placebo (OTHER).

Who is sponsoring clinical trial NCT06889584?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.